ArticleThoracic cancer2022

Promotor methylation status of MAPK4 is a novel epigenetic biomarker for prognosis of recurrence in patients with thymic epithelial tumors.

Wei Guan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.